2011
DOI: 10.1590/s0104-66322011000400003
| View full text |Cite
|
Sign up to set email alerts
|

Abstract: -Flagellin is the structural protein and most abundant component of bacterial flagella. The flagellum filament contains around 20,000 -100,000 subunits of 50 kDa flagellin that can have diverse biotechnological applications such as vaccine adjuvant and cellular protector during chemo-and radiotherapy. The main aim of this work was to study a production process of purified native FliC flagellin of Salmonella Typhimurium. The culture conditions in shakers were established with medium devoid of animal-derived com… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 31 publications
0
2
0
1
Order By: Relevance
“…Since bacterial flagellin has potential as a vaccine adjuvant, a rDNA flagellin production technology would be beneficial. Currently, flagellin proteins are produced by homogenization, heat treatment, and filtration of the flagellin filament pellets prepared from cell pellets (Braga et al, 2008; Oliveira et al, 2011; Zhang et al, 2003). Abdulla et al (2012) expressed the flagellin gene flic from S. typhimurium into E. coli .…”
Section: Introductionmentioning
confidence: 99%
“…Since bacterial flagellin has potential as a vaccine adjuvant, a rDNA flagellin production technology would be beneficial. Currently, flagellin proteins are produced by homogenization, heat treatment, and filtration of the flagellin filament pellets prepared from cell pellets (Braga et al, 2008; Oliveira et al, 2011; Zhang et al, 2003). Abdulla et al (2012) expressed the flagellin gene flic from S. typhimurium into E. coli .…”
Section: Introductionmentioning
confidence: 99%
“…Besides the recognized importance as a pathogen itself, in the last years, Salmonella has gained increasing attention in the biotechnological area as a potential host to produce several pharmaceutical compounds (Silva et al, 2014). Among the products that can be produced with Salmonella typhimurium are flagellin, capsular polysaccharide Vi, lipopolysaccharides, and vaccines, with applications in human and veterinary medicine (Braga et al, 2010;Kong et al, 2013;Kothari et al, 2014;Oliveira et al, 2011). Attenuated strains of Salmonella are being used as Live Bacterial Vectors (LBV), for immunization against itself or to deliver heterologous antigens (Silva et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…Так, наибольшее число клеток R. solanacearum, имеющих жгутики, на- При химической идентификации препаратов флагеллинов показано (табл.1), что они состоят из белка (55-92%), углеводов (7-25%), а также в незначительных количествах обнаружены нуклеиновые кислоты (от 0.5 до 3.3%). Известно [16], что флагеллины построены из четырех структурных доменов: терминальные cпиральные D0 (включающий С-и N-концы) и D1, локализованные внутри нити, а также D2 и D3 домены, которые находятся на ее поверхности. Изучение первичной структуры флагеллинов из различных видов бактерий свидетельствует о высокой степени гомологии аминокислотных последовательностей их D0 и D1 доменов -80 и 60% гомологии соответственно и всего 20% гомологии в центральном домене.…”
unclassified